US Stock MarketDetailed Quotes

PRQR ProQR Therapeutics

Watchlist

3.5400
-0.0800-2.21%

Close Nov 25 16:00 ET

3.5400
0.00000.00%

Post 19:15 ET

374.91MMarket Cap-11238P/E (TTM)

ProQR Therapeutics Stock Forum

Stock_Drift

Nov 5 16:19

After Hours Ticks. 5:18pm

$Pagaya Technologies (PGY.US)$ $XORTX Therapeutics (XRTX.US)$ $Mercury Systems (MRCY.US)$ $Yunji (YJ.US)$ $My Size (MYSZ.US)$ $ProQR Therapeutics (PRQR.US)$ $loanDepot (LDI.US)$ $Sonder Holdings (SOND.US)$ $Revolve Group (RVLV.US)$ $BiomX (PHGE.US)$ $Qualys (QLYS.US)$
📊⚡️📊

Moonlight was in

Oct 16 13:51

$ProQR Therapeutics (PRQR.US)$ 300%+ let’s she go

Tarzanman™

Oct 16 11:01

$ProQR Therapeutics (PRQR.US)$
big offering watchout

Tarzanman™

Oct 16 09:03

💰💸

Share Your Profit/Loss

Jaguar8

Apr 22 15:33

$ProQR Therapeutics (PRQR.US)$
NEWS
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, today announced it will present new preclinical data for its proprietary Axiomer™ RNA editing technology platform, including the first preclinical data for its AX-0810 pipelin...

JESSE JAMES8832

Jan 19 06:22

ProQR Therapeutics Highlights New Platform Data From Presentation On Axiomer RNA Editing Technology, Company Says Platform Demonstrates Robust In Vivo Editing Capabilities Reporting Up To 70% Editing

$ProQR Therapeutics (PRQR.US)$

Moomoo AI

Jan 18 06:57

ProQR Therapeutics' short term liquidity and more cash than debt suggest it can manage its debt safely. Its 38% revenue growth is a positive sign, indicating potential for further strong growth.